SCHEMBL30709495

SCHEMBL30709495

c1ccc(-c2cccc(-c3ccccc3-c3c(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
DUSP3 P51452 1/20 0.35
ASIC3 Q9UHC3 1/20 0.34
MAPK14 Q16539 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30
TUBB4B P68371 1/20 0.30
TUBB3 Q13509 1/20 0.30
TUBB2A Q13885 1/20 0.30
TUBB8 Q3ZCM7 1/20 0.30
TUBA3E Q6PEY2 1/20 0.30
TUBA1A Q71U36 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148674 0.92 MEN1 (0.36) KMT2AMEN1RAB9ADUSP3
SCHEMBL30709653 0.91 TNF (0.36) KMT2AMEN1RAB9ADUSP3MAPK14
SCHEMBL30709352 0.91 TNF (0.39) KMT2AMEN1RAB9ADUSP3MAPK14
SCHEMBL22148589 0.90 ALDH1A1 (0.36) KMT2AMEN1RAB9AKDM4E
SCHEMBL30709398 0.89 MEN1 (0.35) KMT2AMEN1RAB9AMAPK14KDM4E
SCHEMBL30709451 0.88 MEN1 (0.33) KMT2AMEN1RAB9A
SCHEMBL22148775 0.87 CYP19A1 (0.35) KMT2AMEN1DUSP3KDM4EATM
SCHEMBL30709372 0.87 CLK4 (0.34) KMT2AMEN1RAB9AKDM4E
SCHEMBL22148776 0.87 SMN1; SMN2 (0.35) KMT2AMEN1RAB9ADUSP3KDM4E
SCHEMBL30709490 0.87 SMN1; SMN2 (0.35) KMT2AMEN1RAB9ADUSP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 KMT2A 4367/4885MEN1 2193/4885RAB9A 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.